Appointment/Re-appointment of Auditors
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 0.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krsnaa Diagnostics reported FY26 standalone PAT of ₹1,026.75 million, up 24% from ₹828.08 million in FY25, while consolidated PAT grew 30.7% to ₹1,014.31 million. Standalone revenue from operations was largely flat at ₹6,909.47 million (vs ₹6,816.95 million), though consolidated revenue grew 7.8% to ₹7,727.74 million. The company received unmodified (clean) audit opinions from MSKA & Associates. However, an Emphasis of Matter was raised regarding Income Tax search proceedings resulting in a demand order of ₹626.90 million, against which the company has filed appeals. The Board recommended a final dividend of ₹2 per share (40% face value) and proposed appointing M/s Kirtane & Pandit LLP as statutory auditors for FY26-27 to FY30-31, subject to shareholder approval.
Strong PAT growth (24-30%) and clean audit opinions are positive signals, though flat standalone revenue growth raises concerns. The ₹626.90 million tax demand and change in auditors warrant attention despite management's view of non-material impact.